EMTRICITABINE MANUFACTURING SUPPLY AGREEMENT AMENDMENT NO. 1Emtricitabine Manufacturing Supply Agreement • August 9th, 2010 • Gilead Sciences Inc • Biological products, (no disgnostic substances)
THIS AMENDMENT (the “Amendment No. 1”) to the Emtricitabine Manufacturing Supply Agreement is entered into as of April 30, 2010, by and between Evonik Degussa GmbH (formerly known as Degussa AG), a German limited liability company (“Evonik”) and Gilead Sciences Limited, an Irish limited company (“GSL”).
